Drug Profile
Research programme: amyloid inhibitors - Advanced Life Sciences
Alternative Names: ALS-499; ALS-633Latest Information Update: 27 Apr 2011
Price :
$50
*
At a glance
- Originator Argonne National Laboratory
- Developer Advanced Life Sciences
- Class Peptides
- Mechanism of Action Amyloid inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Alzheimer's disease
Most Recent Events
- 25 Oct 2006 This programme is still in active development
- 21 May 2003 Preclinical trials in Alzheimer's disease in USA (unspecified route)